Annual Reports

  • 10-K (Feb 21, 2017)
  • 10-K (Feb 12, 2016)
  • 10-K (Feb 13, 2015)
  • 10-K (Apr 3, 2014)
  • 10-K (Feb 14, 2014)
  • 10-K (Feb 15, 2013)

 
Quarterly Reports

 
8-K

 
Other

Bristol-Myers Squibb Company 8-K 2007

Documents found in this filing:

  1. 8-K
  2. Ex-99.1
  3. Graphic
  4. Graphic
Press release dated December 4, 2007

Exhibit 99.1

LOGO

 

Contact:        Media:    Investors:
   Jeff MacDonald    John Elicker
   Communications    Investor Relations
   212-546-4824    212-546-3775
   jeffrey.macdonald@bms.com    john.elicker@bms.com

BRISTOL-MYERS SQUIBB NAMES ALAN J. LACY TO

BOARD OF DIRECTORS

New York, (December 4, 2007) – Bristol-Myers Squibb Company (NYSE: BMY) today announced that Alan J. Lacy has been elected to its Board of Directors, effective January 2, 2008. Lacy will serve as a member of the Audit Committee.

Lacy, 54, is currently a senior advisor to Oak Hill Capital Partners, L.P., a private equity investment firm. From 1994 to 2006, he was employed by Sears, Roebuck and Co. and following the acquisition of the company, Sears Holdings Corporation. He held executive level positions of increasing responsibility in finance and operations, including his service as chief executive officer from 2000 to 2005. He also served as vice chairman from 2005 to 2006.

“We are very pleased to have a person of Alan’s broad business and financial experience join our Board,” said James D. Robinson III, chairman, Bristol-Myers Squibb. “He adds to an already outstanding group of directors.”

“Alan is a man of high integrity and business acumen,” added James M. Cornelius, chief executive officer, Bristol-Myers Squibb. “We look forward to his contributions as a director of our company as we continue to evolve into a next generation biopharma enterprise.”

Bristol-Myers Squibb is a global biopharmaceutical and related healthcare products company whose mission is to extend and enhance human life.

###

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki